BUSINESSSCMP CHINA
Chinese medical device makers push into Europe as anti-corruption squeeze bites at home
Chinese medical device companies are expanding into the European market amid anti-corruption policies and declining domestic hospital purchases, which have reduced their revenue. Government-backed hospital purchases in China fell 12% year-on-year in the first five months of 2026 due to a new anti-corruption probe.
Mentioned
Related Signal
Adjacent reporting
- Chinese medical device makers push into Europe as anti-corruption squeeze bites at home
- STAT+: Pharmalittle: We’re reading about U.S. pressuring Germany on drug prices, FDA upheaval and biotech clinical trials, and more
- Czechia advances as a top clinical trials hub – but global rivals are closing in [Advocacy Lab]
- STAT+: As the U.S. looks on, European countries feel growing pressure on drug prices
- Investment in Israeli health tech startups dove 40% in 2025 – report
- Organ trade racket: ED expands probe, summons doctors part of Kerala hospitals’ internal evaluation committees